España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
LakeShore Biopharma
LSB
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.81
0.06
2.18%
At close: -
$2.89
0.08
2.85%
After Hours: Jan 27, 8:59 AM EDT
Get Report
Comment
LakeShore Biopharma (LSB) Forecast
News
Earnings
LakeShore Biopharma (LSB) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for LakeShore Biopharma (NASDAQ:LSB) Stock
LakeShore Biopharma Stock (NASDAQ: LSB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 19, 2024
LakeShore Biopharma Sees FY25 Revenues To Be ...
Benzinga Newsdesk
LakeShore Biopharma H1 2025 EPS $0.02; Revenu...
Benzinga Newsdesk
Monday, December 16, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Friday, December 13, 2024
Reported Earlier, LakeShore Biopharma Takes D...
Benzinga Newsdesk
Thursday, November 07, 2024
LakeShore Biopharma Initiates Biologics Licen...
Benzinga Newsdesk
Tuesday, November 05, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Tuesday, October 29, 2024
LakeShore Biopharma Regains Compliance With N...
Benzinga Newsdesk
Friday, October 25, 2024
LakeShore Biopharma Receives Phase III Trial ...
Benzinga Newsdesk
Wednesday, October 23, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Friday, October 11, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Tuesday, October 08, 2024
LakeShore Biopharma shares are trading higher...
Benzinga Newsdesk
LakeShore Biopharma Sees Prelim. 1H Revenue R...
Benzinga Newsdesk
Thursday, October 03, 2024
Trading Halt: Halt status updated at 7:50:00 ...
Benzinga Newsdesk
Monday, September 30, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Friday, September 27, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Wednesday, September 04, 2024
LakeShore Biopharma Appoints Xu Wang As New C...
Benzinga Newsdesk
Thursday, August 15, 2024
LakeShore Biopharma shares are trading higher...
Benzinga Newsdesk
LakeShore Biopharma FY24 Revenue RMB573.4M, D...
Benzinga Newsdesk
